DILLARD'S, INC. DDS
NYSE · XNYS · stock · Retail-Department Stores
Chart by TradingView
5/9
Piotroski F — financial health
—
Altman Z″ — distress risk
85.0%
Dividend payout · at-risk
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $6.5B | $570.2M | $2.6B | $623.6M | $1.8B |
| 2025 | $6.5B | $593.5M | $2.6B | $609.6M | $1.8B |
| 2024 | $6.9B | $738.8M | $2.7B | $750.6M | $1.7B |
| 2023 | $6.9B | $891.6M | $2.9B | $828.3M | $1.6B |
| 2022 | $6.5B | $862.5M | $2.7B | $1.2B | $1.5B |
| 2021 | $4.4B | -$71.7M | $1.2B | $192.5M | $1.4B |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000028917 · as of 2026-01-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.